3rd Consecutive Win For Bayer In Roundup Lawsuit
3rd Consecutive Win For Bayer In Roundup Lawsuit
Introduction
Bayer has been awarded a win by a Missouri jury in the Roundup lawsuit where a man alleged that he got diagnosed with non-Hodgkin's lymphoma due to the usage of the company's weedkiller.
The trial kick-started in early May and went on for over a month finally being rewarded in favor of Bayer. It is the third consecutive win for the company over its weedkiller.
As per the plaintiff's lawyers, Bayer sold defective herbicide under the name of Roundup Ready to Use brand, which was used by the plaintiff, and exposure to it resulted in the development of non-Hodgkin's lymphoma for the plaintiff in 2016. The case focused on the company's failure to warn the customers about the allegedly defective products.
The lawsuit is a part of the ongoing wave of litigation that involves tens of thousands of people who have sued Bayer by alleging that its product Roundup caused cancer in them. The plaintiff's lawyer said that they are disappointed by the verdict and are considering options to fight back against the verdict.
The plaintiff's lawyers are looking forward to a four-plaintiff trial slated to start in October against Monsanto in St. Louis County. In a similar lawsuit which would be overlooked by a different jury in Jackson County, a plaintiff's twin brother has alleged that the company's weedkiller caused cancer in him.
A spokesperson for Bayer said that the weedkiller does not cause cancer, and the plaintiff's cancer was a result of his smoking habit and not the exposure to Roundup.
Currently, Bayer faces tens of thousands of Roundup lawsuits from the people who used or got exposed to the weedkiller, which eventually resulted in injuries for them, including cancer. All the lawsuits allege that the company withheld the information that exposure to Roundup could have adverse effects on health.
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…